Wai Yuen Tong Medicine Holdings Ltd - ESG Rating & Company Profile powered by AI
Browse to the bottom of the webpage for potential risks for Wai Yuen Tong Medicine Holdings Ltd based on industry, location and marketcap. The analysis of Wai Yuen Tong Medicine Holdings Ltd incorporates data from across the web and also from public documents by Wai Yuen Tong Medicine Holdings Ltd. The article contains a questions and answers section about Wai Yuen Tong Medicine Holdings Ltd.
Wai Yuen Tong Medicine Holdings Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 7.1; made up of an environmental score of 8.0, social score of 8.0 and governance score of 5.3.
7.1
High ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
217 | Takara Bio Inc | 7.2 | High |
217 | Ultragenyx Pharmaceutical Inc | 7.2 | High |
224 | Wai Yuen Tong Medicine Holdings Ltd | 7.1 | High |
224 | Celularity Inc | 7.1 | High |
224 | Bilcare Ltd | 7.1 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Wai Yuen Tong Medicine Holdings Ltd have an accelerator or VC vehicle to help deliver innovation?
Does Wai Yuen Tong Medicine Holdings Ltd disclose current and historical energy intensity?
Does Wai Yuen Tong Medicine Holdings Ltd report the average age of the workforce?
Does Wai Yuen Tong Medicine Holdings Ltd reference operational or capital allocation in relation to climate change?
Does Wai Yuen Tong Medicine Holdings Ltd disclose its ethnicity pay gap?
Does Wai Yuen Tong Medicine Holdings Ltd disclose cybersecurity risks?
Does Wai Yuen Tong Medicine Holdings Ltd offer flexible work?
Does Wai Yuen Tong Medicine Holdings Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Wai Yuen Tong Medicine Holdings Ltd disclose the number of employees in R&D functions?
Does Wai Yuen Tong Medicine Holdings Ltd conduct supply chain audits?
Does Wai Yuen Tong Medicine Holdings Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Wai Yuen Tong Medicine Holdings Ltd conduct 360 degree staff reviews?
Does Wai Yuen Tong Medicine Holdings Ltd disclose the individual responsible for D&I?
Does Wai Yuen Tong Medicine Holdings Ltd disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Wai Yuen Tong Medicine Holdings Ltd disclose current and / or historical scope 2 emissions?
Does Wai Yuen Tong Medicine Holdings Ltd disclose water use targets?
Does Wai Yuen Tong Medicine Holdings Ltd have careers partnerships with academic institutions?
Did Wai Yuen Tong Medicine Holdings Ltd have a product recall in the last two years?
Does Wai Yuen Tong Medicine Holdings Ltd disclose incidents of discrimination?
Does Wai Yuen Tong Medicine Holdings Ltd allow for Work Councils/Collective Agreements to be formed?
Has Wai Yuen Tong Medicine Holdings Ltd issued a profit warning in the past 24 months?
Does Wai Yuen Tong Medicine Holdings Ltd disclose parental leave metrics?
Does Wai Yuen Tong Medicine Holdings Ltd disclose climate scenario or pathway analysis?
Does Wai Yuen Tong Medicine Holdings Ltd disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Wai Yuen Tong Medicine Holdings Ltd disclose the pay ratio of women to men?
Does Wai Yuen Tong Medicine Holdings Ltd support suppliers with sustainability related research and development?
Does Wai Yuen Tong Medicine Holdings Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Wai Yuen Tong Medicine Holdings Ltd reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Wai Yuen Tong Medicine Holdings Ltd involved in embryonic stem cell research?
Does Wai Yuen Tong Medicine Holdings Ltd disclose GHG and Air Emissions intensity?
Does Wai Yuen Tong Medicine Holdings Ltd disclose its waste policy?
Does Wai Yuen Tong Medicine Holdings Ltd report according to TCFD requirements?
Does Wai Yuen Tong Medicine Holdings Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Wai Yuen Tong Medicine Holdings Ltd disclose energy use targets?
Does Wai Yuen Tong Medicine Holdings Ltd disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Wai Yuen Tong Medicine Holdings Ltd have a policy relating to cyber security?
Have a different question?
Potential Risks for Wai Yuen Tong Medicine Holdings Ltd
These potential risks are based on the size, segment and geographies of the company.
Wai Yuen Tong Medicine Holdings Limited, an investment holding company, manufactures, processes, and retails traditional Chinese medicines, Western pharmaceutical products, and health food and personal products in Hong Kong, Mainland China, Macau, and internationally. The company offers Chinese medicines and health food products under the Wai Yuen Tong brand name; and Western pharmaceutical and personal care products under the Madame Pearl's and Pearl's brands. It also engages in the investment, holding, and selling of properties; provision of financial services; and agricultural produce exchange market operation. As of March 31, 2022, the company operated 63 retail stores in Hong Kong. The company was founded in 1897 and is headquartered in Kowloon Bay, Hong Kong. Wai Yuen Tong Medicine Holdings Limited is a subsidiary of Rich Time Strategy Limited.